Mayo Clinic Comprehensive Cancer Center
@mayocancercare
Personalized #CancerTreatment + leading-edge #CancerResearch and #ClinicalTrials = unparalleled #CancerCare. mayoclinic.org/appointments
ID: 2396756364
http://www.mayoclinic.org/cancercenter 18-03-2014 20:52:34
25,25K Tweet
13,13K Followers
1,1K Following
Team work and the trust our patients put on all of us Giving us hope that one day we will find a cure for cancer Mayo Clinic Neuro Mayo Clinic Mayo Clinic Comprehensive Cancer Center Brain Tumor Stem Cell Lab
This experience shows us that it is worth fighting for our patients with leptomeningeal carcinomatosis - 82 months from diagnosis and going strong! Proud to work with my team Mayo Clinic Mayo Clinic Comprehensive Cancer Center link.springer.com/article/10.100…
Beyond thrilled to have presented my first poster at #ASCO25. Immensely grateful to my mentors Dr Tefferi and Naseema Gangat for their guidance and support! ASCO Mayo Clinic Comprehensive Cancer Center
Come hear Plasma Cell Pete present #ASCO25 this morning on this important long term follow-up results. Impressive results for #mmsm patients in late line therapies. Mayo Clinic Comprehensive Cancer Center
Hematology/Oncology Resident Sarah Premji, MD discusses her #ASCO25 abstract: "Estrogen receptor expression in residual #BreastCancer following neoadjuvant chemotherapy." Read the abstract here: ascopubs.org/doi/10.1200/JC…
Great collaboration and partnership with Saranya Chumsri Mayo Clinic Comprehensive Cancer Center on #vaccine #immunotherapy for #MBC BriaCell Therapeutics Corp. Sylvester Comprehensive Cancer Center
A study led by Mayo Clinic Hematology-Oncology Fellowship's Sikander Ailawadhi, M.D., and presented at #ASCO25, suggests isatuximab for relapsed/refractory #MultipleMyeloma via subcutaneous on-body delivery system is as effective as traditional IV infusions. Read the abstract: ascopubs.org/doi/10.1200/JC…
Thor Halfdanarson discusses how NCCN guidelines now include cabozantinib as a category 1 recommendation for GI NETs after treatment with everolimus or lutetium-177 dotatate, with slightly different recommendations for pancreatic, lung, thymic NETs. Mayo Clinic Comprehensive Cancer Center hubs.li/Q03pLch60
WATCH: Thor Halfdanarson (Mayo Clinic Comprehensive Cancer Center) discusses how treatment sequencing for neuroendocrine tumors is less important than ensuring patients receive all available treatments. hubs.li/Q03pLfkc0
Register now for the Mayo Clinic Oncology Review 2025 on July 19 with course director Thor Halfdanarson. This course offers in-person and virtual attendance options. #MedEd #MedOnc
Excited to have been featured on Susan G. Komen’s Real Pink podcast discussing Robotic Nipple Sparing Mastectomy. Mayo Clinic Mayo Clinic Comprehensive Cancer Center Intuitive Susan G. Komen podcasts.apple.com/us/podcast/rea…
As a leading National Cancer Institute-designated Comprehensive Cancer Center, Mayo Clinic is uniquely qualified to bring #CarbonIonTherapy to the Americas. With this bold step forward, we are bringing new hope for patients diagnosed with the most aggressive and treatment-resistant cancers.
Come talk to Jacob Shreve tonight #EHA25 poster session to learn how we are using AI to predict CRS long before the first symptom. Earlier prediction=earlier planning & opportunity for risk adapted management. Key to expand access to #CART #BsAb Mayo Clinic Comprehensive Cancer Center Jonas Paludo
Happening now #EHA25 poster session. Dr. Melinda Tan Mayo Clinic Comprehensive Cancer Center presents cytokine and cellular immune profile distinctions among CRS vs low grade vs high grade IEC-HS post #CART #lymsm #mmsm predictors at early onset help clinicians tailor management. ASTCT Supriya Gupta, MD
Complex care feels seamless Mayo Clinic in Florida. We recently treated recurrent #rectalcancer with total sacrectomy, pelvic exent, aortic bifurcation resection w/homograft & VRAM. 1 patient, 5 surgical teams! MultiD planning w/ #teamwork helps makes the unresectable resectable!
